<DOC>
	<DOCNO>NCT01247168</DOCNO>
	<brief_summary>This study conduct test study drug AZD2461 see may work treat solid tumor . The main purpose study determine safety tolerability AZD2461 . This first time drug give human class first time man study . Its main purpose establish safe dosage drug provide additional information potential side effect drug may cause . The study also assess blood level action AZD2461 body period time indicate whether drug therapeutic effect solid tumor .</brief_summary>
	<brief_title>An Open-Label , Dose-Escalation Study AZD2461</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients confirm diagnosis solid tumor malignancy responsive standard therapy effective therapy . Eastern Cooperative Group ( ECOG ) Performance Status score 0 1 Patients must 18 year age Using adequate contraceptive measure , surgically sterile postmenopausal Patients enter study must willing provide tissue previous tumor biopsy ( available ) correlative testing . If tissue available , patient still eligible enrollment study.. Patients currently receive cancer therapy Use investigation anticancer drug major surgery , radiotherapy immunotherapy last 21 day cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Refractory</keyword>
	<keyword>Solid tumor</keyword>
	<keyword>Cancer</keyword>
</DOC>